AI model predicts cancer survival from facial features in new study

Key points

• The FAHR-Face model, developed by Mass General Brigham, uses AI to analyze facial photographs for health assessments.
• Two tools were created: FAHR-FaceAge estimates biological age, while FAHR-FaceSurvival directly predicts cancer mortality risk.
• FAHR-FaceSurvival focuses on areas under the eyes and around the nasal bridge, while FAHR-FaceAge analyzes nasolabial folds, forehead, and temples.
• The model was trained on more than 40 million facial images, including 35,000 photos of cancer patients from the US and Netherlands.
• Patients appearing five or more years older than their chronological age had a 21% higher risk of dying within four years of radiotherapy.
• Lifestyle factors such as smoking, heavy alcohol use, and drug use were linked to looking biologically older.

Background

This development builds on earlier AI initiatives in medical diagnostics, such as the 2025 launch of the FaceAge tool for estimating biological age. It follows a trend of integrating AI into healthcare for personalized medicine, though it remains distinct from unrelated tech developments like Apple's photo authentication features or NASA's Mars imaging projects covered in recent archives.

How outlets are covering it

The Guardian and Washington Post highlight the scale of the training data, noting the 40 million images used to create the foundation model. The BBC and Mass General Brigham emphasize the specific facial regions analyzed, with the BBC noting the tool's application across various cancer types. While all sources agree on the potential for personalized treatment, The Washington Post and BBC stress the preliminary nature of the findings. Prof. Miroslaw Bober of the University of Surrey, cited by the BBC, warns that claims about tracking aging over time are premature and that the tool needs testing against clinical judgment. The Mass General Brigham release provides detailed author disclosures and funding sources, including EU European Research Council support, which other outlets did not detail.

Why it matters

This AI tool could revolutionize how doctors assess patient frailty and physical reserve before recommending intensive treatments like surgery or radiation. By providing a quantitative, scalable method for health assessment, it may help personalize care for an aging population. However, its current limitations in diversity and clinical validation mean it is not yet ready for widespread hospital use, highlighting the ongoing need for rigorous testing in medical AI applications.

What to watch

The research team is inviting the public to participate in the FaceAge Research Study by uploading facial photos to receive biological age estimates and contribute to data validation. Further studies are needed to test the tools across different hospitals, patient groups, and ethnicities to ensure reliability and accuracy before potential clinical adoption.